Literature DB >> 1666147

Mouse models of short- and long-term foreign body in the urinary bladder: analogies to the bladder segment of urinary catheters.

D E Johnson1, C V Lockatell, M Hall-Craggs, J W Warren.   

Abstract

Catheter-associated bacteriuria is the most common infection occurring in hospitals, where urethral catheters are generally in place for a few days, and in nursing homes, where catheters may be in place for months or years. We developed murine models with intrabladder urinary catheters for studying complications of bacteriuria in short- and long-term catheterization. In the short-term model, a catheter segment was inserted transurethrally and lay free within the bladder lumen. Half of the animals expelled segments during a 2-to-7-day period, durations similar to catheterizations in hospitalized patients. For studies of long-term catheter use, the catheter segment was secured within the bladder by a single suture for up to 12 months. Antibiotics administered for 7 days after catheter placement and housing mice in cages with wire screen floors reduced spontaneous bacteriuria to an acceptably low incidence rate of only 7%. Proteus mirabilis bacteriuria of high concentration provoked the same complications that are common in patients with long-term catheters: acute pyelonephritis, chronic renal inflammation, and struvite stone formation. These models allow inoculation of the bacteria of interest and are suitable for studies of short- and long-term foreign body-associated bacteriuria and its complications.

Entities:  

Mesh:

Year:  1991        PMID: 1666147

Source DB:  PubMed          Journal:  Lab Anim Sci        ISSN: 0023-6764


  8 in total

1.  Evaluation of the bacterial distribution within the biofilm by denaturing gradient gel electrophoresis in the rat model of urinary catheters.

Authors:  Hyun-Sop Choe; Hyun-Jung Kim; Seung-Ju Lee; Ji-Youl Lee; Sang-Seob Lee; Yong-Hyun Cho
Journal:  Int Urol Nephrol       Date:  2013-04-07       Impact factor: 2.370

2.  Visualization of Proteus mirabilis within the matrix of urease-induced bladder stones during experimental urinary tract infection.

Authors:  Xin Li; Hui Zhao; C Virginia Lockatell; Cinthia B Drachenberg; David E Johnson; Harry L T Mobley
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

3.  Noninvasive biophotonic imaging for monitoring of catheter-associated urinary tract infections and therapy in mice.

Authors:  Jagath L Kadurugamuwa; Kshitij Modi; Jun Yu; Kevin P Francis; Tony Purchio; Pamela R Contag
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

4.  Struvite urolithiasis and chronic urinary tract infection in a murine model of urinary diversion.

Authors:  Brian Becknell; Ashley R Carpenter; Brad Bolon; John R Asplin; Susan E Ingraham; David S Hains; Andrew L Schwaderer; Kirk M McHugh
Journal:  Urology       Date:  2013-03-20       Impact factor: 2.649

Review 5.  Strengths and Limitations of Model Systems for the Study of Urinary Tract Infections and Related Pathologies.

Authors:  Amelia E Barber; J Paul Norton; Travis J Wiles; Matthew A Mulvey
Journal:  Microbiol Mol Biol Rev       Date:  2016-03-02       Impact factor: 11.056

6.  Catheter-associated urinary tract infection by Pseudomonas aeruginosa is mediated by exopolysaccharide-independent biofilms.

Authors:  Stephanie J Cole; Angela R Records; Mona W Orr; Sara B Linden; Vincent T Lee
Journal:  Infect Immun       Date:  2014-03-04       Impact factor: 3.441

7.  Contribution of Proteus mirabilis urease to persistence, urolithiasis, and acute pyelonephritis in a mouse model of ascending urinary tract infection.

Authors:  D E Johnson; R G Russell; C V Lockatell; J C Zulty; J W Warren; H L Mobley
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

8.  Comparison of Escherichia coli strains recovered from human cystitis and pyelonephritis infections in transurethrally challenged mice.

Authors:  D E Johnson; C V Lockatell; R G Russell; J R Hebel; M D Island; A Stapleton; W E Stamm; J W Warren
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.